Drug prices in France: Summary of the recent developments in the French pricing system
Jacquet, Laurie Rachet
Drug prices in France: Summary of the recent developments in the French pricing system - 2018.
46
This article presents the different aspects of determining the price of reimbursable medicines in France. We discuss how drug prices are set according to drug status : in commercial distribution (brand-name and generic drugs) and in hospital distribution ( liste de retrocession [retrocession list] and liste en sus [supplementary list]). Pricing issues and other recent developments are discussed, as well as the role of relevant institutions such as the Healthcare Products Pricing Committee (CEPS) and the French National Authority for Health (HAS).
Drug prices in France: Summary of the recent developments in the French pricing system - 2018.
46
This article presents the different aspects of determining the price of reimbursable medicines in France. We discuss how drug prices are set according to drug status : in commercial distribution (brand-name and generic drugs) and in hospital distribution ( liste de retrocession [retrocession list] and liste en sus [supplementary list]). Pricing issues and other recent developments are discussed, as well as the role of relevant institutions such as the Healthcare Products Pricing Committee (CEPS) and the French National Authority for Health (HAS).
Réseaux sociaux